The incidence of cutaneous squamous cell carcinoma (cSCC) are growing in the United States and epidemiologic and outcomes data are likely to have underestimated the burden of the disease. New therapies are emerging for the management of advanced cSCC that have the potential to meaningfully alter outcomes for a select group of patients who are unlikely to be cured with surgery.

The CME-accredited educational curricula provided here by RMEI are designed to engage practicing clinicians with actionable insights for improving the delivery of patient care. Some of the world’s foremost clinical experts on cSCC are featured as faculty, in video and audio dialogues, with real patients. New activities and live meetings are added regularly, so be sure to check back for updates!

Advanced cSCC: What to Do When Surgery Just Isn't Going to Cut It

Tuesday, 13 October 2020 Vilnius, Lithuania While attending EADO 2020, please join our faculty as they address pressing questions about unresectable cutaneous squamous cell carcinoma (CSCC). Using real-world patient cases, they will demonstrate how...

Read more:

cSCC Patient Clinic

This 3-patient case activity explores clinical topics in cSCC from a surgical, dermatologic, and oncologic perspective. ...

Read more:

Selecting the RIGHT Patient for Systemic Therapy in cSCC: A Care Team Forum

This roundtable combines a multidisciplinary specialist panel, patient & caregiver to discuss selecting patients with cSCC for appropriate treatments. ...

Read more:

New Systemic Options for Managing cSCC: A Care Team Forum

In this patient-faculty discussion, learn more about the efficacy and safety of new treatment strategies for cSCC tumors unamenable to surgery. ...

Read more: